Secukinumab begins to take effect after a few injections

Secukinumab is a prescription drug used to treat adults with active ankylosing spondylitis and people 6 years and older with moderate to severe plaque psoriasis (involving large or multiple areas of the body) who may benefit from injections or medications (systemic treatment) or light therapy (purple psoriasis alone) External or UV light or treatment used with systemic therapy), with active enthesitis-associated arthritis in persons 4 years and older, with active psoriatic arthritis in persons 2 years and older, and adults with active nonradiographic axial spondyloarthritis and objective signs of inflammation.

In some cases, the proteinIL-17A can cause inflammation, pain, and damage to certain parts of the body, such as joints. Secukinumab works by blocking the action of this protein to reduce inflammation and the problems it can cause, such as joint pain and stiffness. This is a long-term treatment, and depending on your condition, you may need to take secukinumab for three weeks to a year before you start to see benefits.

Secukinumab The original drug has been launched in China and has entered the scope of Class B medical insurance. However, domestic patients who can purchase this drug are limited to eligible patients with psoriasis and ankylosing spondylitis. Patients who are not eligible for medical insurance reimbursement can only purchase it at their own expense. The price of each box of 150mg/ML is about RMB 1,000. SecukinumabThe original drug has also been launched overseas. The specifications of the Turkish original versionThe price per box of 150mg/ML is about 1,500 yuan, and the European version is 150m. The price of each box of g/ML*2 is around RMB 15,000 (the price may fluctuate due to the exchange rate). The ingredients of foreign original drugs and domestic original drugs are basically the same. Currently, there are no generic secukinumab drugs on the market.